GO:0060198 clathrin-sculpted vesicle: Components & Research

Clathrin-sculpted vesicles (GO:0060198) are a specialized class of transport intermediates that form after the clathrin coat is removed from endocytic or secretory vesicles. They are defined in the Gene Ontology as a clathrin-sculpted lipid bilayer membrane-enclosed vesicle after clathrin release, distinguishing them from coated pits and coated vesicles that still retain clathrin. These vesicles are critical for delivering cargo to specific intracellular destinations, including synaptic vesicle precursors and neurotransmitter transporters in neurons. Recent work on vascular dementia has highlighted that the gene expression of acetylcholine and glutamate clathrin-sculpted transport vesicles is altered in female patients, alongside increased levels of methylenetetrahydrofolate reductase and cystathionine β-synthase. This underscores the clinical relevance of understanding how these vesicles are formed, regulated, and how their dysfunction contributes to disease. For researchers, GO:0060198 provides a precise ontological handle to annotate and study post-uncoating vesicle populations, enabling targeted experiments in neurobiology, cell biology, and translational medicine.

In our own words, GO:0060198 describes a vesicle that has completed the clathrin uncoating step, leaving a lipid bilayer membrane-enclosed compartment that is no longer surrounded by a clathrin lattice. It is a cellular component term that captures the moment after clathrin release, when the vesicle is free to fuse with target membranes or undergo further maturation. This definition is based on the QuickGO entry for clathrin-sculpted vesicle, which emphasizes the absence of the clathrin coat as a defining feature.

GO:0060198 is important because it defines a functionally distinct vesicle population that operates after clathrin uncoating, a step that is often overlooked in favor of studying coated pits and coated vesicles. These vesicles are directly implicated in neurotransmitter transport, as shown by altered expression of acetylcholine and glutamate clathrin-sculpted transport vesicles in vascular dementia. Understanding their composition and regulation can reveal new therapeutic targets for neurodegenerative and vascular cognitive disorders.

The following genes and proteins are key components or cargo of clathrin-sculpted vesicles, based on published literature.

The formation and fate of clathrin-sculpted vesicles are regulated at multiple levels, including the activity of dynamin GTPases, adaptor protein phosphorylation, and lipid composition. In the context of vascular dementia, altered levels of methylenetetrahydrofolate reductase and cystathionine β-synthase are associated with changes in gene expression of acetylcholine and glutamate clathrin-sculpted transport vesicles, suggesting that metabolic and epigenetic factors can influence vesicle cargo. However, the precise regulatory mechanisms linking these enzymes to vesicle function remain to be fully elucidated.

Vascular dementia is associated with increased levels of methylenetetrahydrofolate reductase and cystathionine β-synthase in female patients, along with altered gene expression of acetylcholine and glutamate clathrin-sculpted transport vesicles. These findings suggest that clathrin-sculpted vesicle dysfunction may contribute to the cholinergic and glutamatergic deficits observed in vascular dementia.

Given their role in neurotransmitter transport, clathrin-sculpted vesicles are likely relevant to other neurodegenerative conditions, although direct evidence is currently limited to vascular dementia. Future studies may explore their involvement in Alzheimer's and Parkinson's diseases.

Isolating clathrin-sculpted vesicles from cell lysates using density gradients followed by mass spectrometry can identify their protein composition. This approach has been used to characterize transport vesicles in brain tissue.

Fluorescently tagging clathrin and cargo proteins allows real-time visualization of vesicle uncoating and transport in living cells. This method is valuable for studying dynamics in neurons.

RNA sequencing of patient samples can reveal dysregulation of genes associated with clathrin-sculpted vesicles, as seen in vascular dementia. This provides insights into disease mechanisms.

Genome-wide CRISPR knockout or activation screens can identify genes that affect the formation or function of clathrin-sculpted vesicles. Such screens are powerful for discovering novel regulators.

Researchers studying clathrin-sculpted vesicle-related genes often need to determine whether a candidate gene is causally involved in vesicle formation, cargo sorting, or disease pathogenesis. EDITGENE provides a comprehensive suite of CRISPR services to enable such investigations with high precision and reproducibility.

GO:0060198 (clathrin-sculpted vesicle) represents a key intermediate in vesicle trafficking that forms after clathrin uncoating. Its cargo, including acetylcholine and glutamate transporters, is dysregulated in vascular dementia, highlighting its clinical importance. By leveraging CRISPR-based models and advanced omics, researchers can uncover the molecular mechanisms governing these vesicles and identify new therapeutic targets.